key: cord-0753059-fgy9ry2z
authors: Finsterer, Josef; Scorza, Fulvio A
title: SARS‐CoV‐2 vaccines are not free of neurological side effects
date: 2021-05-17
journal: Acta Neurol Scand
DOI: 10.1111/ane.13451
sha: b3eeaa045cd62865c88133ff56d75e5d11770770
doc_id: 753059
cord_uid: fgy9ry2z

nan

We disagree with the conclusions that SARS-CoV-2 vaccines do not trigger neurological adverse reactions. Though rare, mild and severe neurological side effects have been occasionally reported. 2 Search platforms and data bases to detect scientific reports about neurological adverse events may not be particularly helpful and do not provide many hits, but thorough assessments of various publications and their reference lists may help to find appropriate publications. Data from the mRNA vaccine clinical trials showed that 7 cases out of 37,000 vaccine recipients developed Bell's palsy. 2 of participants reported post-vaccination headache and 60% had myalgia. 3 In the coronavirus vaccine trial, 2 patients with transverse myelitis were reported. 4 In a 57yo man with a history of two previous facial palsies, a third Bell's palsy developed 36 h after the second dose of an mRNA-based SARS-CoV-2 vaccine. 5 Facial palsy has been also reported in a study of patients undergoing a SARS-CoV-2 vaccination with mRNA-based vaccines. 6 There is also one report about a deep venous thrombosis (DVT) following the second dose of an mRNA vaccine. 7 Since DVT is a potential risk factor for ischaemic stroke in case of a patent foramen ovale (PFO), we should recognize that venous thrombosis as a potential side effect of SARS-CoV-2 vaccines may secondarily concern also the neurologist.

In addition to these publications, we observed several patients with neurological compromise, in whom it was conceivable that neu- Overall, we admit that there is a need for the development effective tools against the pandemic and that vaccination is one of these appropriate means. However, vaccines need to be safe, sufficiently tested, thoroughly approved by the authorities and largely available to meet the needs of societies for containing the spreading of the virus. Thus, there is a general responsibility of doctors, developers, producers and publishers to revitalize hibernated life why publication of side effects is a moral responsibility and should not be hindered. Scientists are asked and requested to carefully collect and manage their data and to continue with the publication of reliable data despite the current difficulties and restrictions.

COVID-19, nerves, neurological, neuropathy, SARS-CoV-2

The potential neurological effect of the COVID-19 vaccines: a review

ANA investigates: neurological complications of COVID-19 vaccines

Vaccines for COVID-19: learning from ten phase II trials to inform clinical and public health vaccination programmes

Very Concerned" about Serious Side Effect in Coronavirus Vaccine Trial

Bell's Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy

Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine

Reported orofacial adverse effects of COVID-19 vaccines: the knowns and the unknowns